#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14070	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2312	605.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1571	1571	C	774	C	724	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14070	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2312	605.5	0	HET	.	.	.	C207T	.	207	207	C	594	594	C	803	C,T	601,164	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14070	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2312	605.5	0	HET	.	.	.	C451T,A	.	451	451	C	838	838	C	795	C,T,A	420,330,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25716	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3686	695.9	0	.	n	.	0	T695C	SNP	695	695	T	1106	1106	C	795	C,T	746,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25716	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3686	695.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2382	2382	C	867	C	811	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25716	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3686	695.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2456	2456	A	813	A	770	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25716	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3686	695.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3008	3008	C	782	C	743	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1806	folP	855	855	100.0	folP.l6.c30.ctg.1	1508	118.8	1	SNP	p	R229S	1	.	.	685	687	AGC	998	1000	AGC	191;189;189	A;G;C	182;180;180	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5076	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	145.1	1	SNP	p	S91F	1	.	.	271	273	TTC	617	619	TTC	176;177;177	T;T,C;C	171;170,1;172	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5076	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	145.1	1	SNP	p	D95G	1	.	.	283	285	GGC	629	631	GGC	172;171;171	G;G,A;C	164;163,1;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5076	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	145.1	1	SNP	p	G95N	0	.	.	283	285	GGC	629	631	GGC	172;171;171	G;G,A;C	164;163,1;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1646	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1465	111.9	1	SNP	p	G45D	0	.	.	133	135	GGC	504	506	GGC	191;191;191	G;G;C,T	176;181;181,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	808	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1097	73.3	0	.	n	.	0	A197.	DEL	197	197	A	618	618	A	202	A,G	194,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5296	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	177.9	1	SNP	p	D86N	0	.	.	256	258	GAC	628	630	GAC	235;234;233	G;A;C	214;211;213	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5296	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	177.9	1	SNP	p	R87I	0	.	.	259	261	CGT	631	633	CGT	233;231;227	C,A;G;T	214,1;214;208	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5296	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	177.9	1	SNP	p	R87W	0	.	.	259	261	CGT	631	633	CGT	233;231;227	C,A;G;T	214,1;214;208	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5296	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	177.9	1	SNP	p	S87R	1	.	.	259	261	CGT	631	633	CGT	233;231;227	C,A;G;T	214,1;214;208	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5296	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	177.9	1	SNP	p	S88P	0	.	.	262	264	TCC	634	636	TCC	228;224;228	T;C;C,A	209;208;206,2	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4098	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2693	151.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1446	1448	GGC	178;177;178	G;G;C	165;163;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1233	1235	GCC	198;198;199	G;C;C,A	189;189;189,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1236	1238	ATG	199;199;199	A;T;G,C	191;191;187,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1248	1250	ACC	215;214;216	A;C;C	200;202;204	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1248	1250	ACC	215;214;216	A;C;C	200;202;204	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1749	1751	ACC	169;169;171	A;C;C	155;160;159	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1803	1805	GCG	178;178;178	G;C;G	166;168;166	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1803	1805	GCG	178;178;178	G;C;G	166;168;166	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1926	1928	GGT	155;152;154	G;G;T	142;140;140	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1935	1937	AGC	150;150;149	A;G;C	137;137;136	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3760	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2350	159.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1953	1955	CCG	138;141;142	C,G;C,G;G,GGC	101,3;108,2;111,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5572	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3150	176.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1687	1689	CCG	195;195;200	C;C;G	174;184;183	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2404	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1850	129.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	551	551	C	142	C	137	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.9	porB1b.l15.c17.ctg.1	1437	179.5	0	.	p	.	0	R108L	NONSYN	322	324	CGC	593	595	CTC	240;238;239	C;T;C	221;208;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.9	porB1b.l15.c17.ctg.1	1437	179.5	1	SNP	p	G120K	1	.	.	358	360	AAG	629	631	AAG	214;215;219	A;A;G	203;204;200	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.9	porB1b.l15.c17.ctg.1	1437	179.5	1	SNP	p	N121D	0	.	.	361	363	AAC	632	634	AAC	218;214;213	A;A;C	204;201;199	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2632	porB1b	1038	1038	99.9	porB1b.l15.c17.ctg.1	1437	179.5	1	SNP	p	A121N	1	.	.	361	363	AAC	632	634	AAC	218;214;213	A;A;C	204;201;199	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9852	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4942	198.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1098	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1171	93.2	1	SNP	p	V57M	1	.	.	169	171	ATG	588	590	ATG	245;242;244	A;T;G	227;222;224	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
